Nootropics Market To Reach USD 5.32 Billion By 2026 | Reports And Data

New York, Feb. 19, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global nootropics market was valued at USD 1.96 billion in 2018 and is expected to reach USD 5.32 billion by the year 2026, at a CAGR of 13.2%. Nootropics are compounds that enhance the cognitive performance of an individual. These substance, also known as smart drugs, are a class of ingredients which can boost the memory, enhance creativity levels, decision making capabilities and improve brain performance. Nootropics medication are of two types, prescription and nonprescription. Prescription medication gives stimulant effects, counteracting the symptoms of medical conditions such as attention deficit hyperactivity disorder (ADHD), Alzheimer's disease, or narcolepsy while nonprescription medications are used to boost mental performance due to their cholinergic mechanisms.

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/2509

The market for these substances is anticipated to get augmented by factors such as the increasing demand for brain boosters owing to the competitive work environment across various domains, rising demand from the sports industry for brain and improved decision making, and the growing awareness regarding mental illnesses. However, the side effects associated with regular consumption of these pills, lack of awareness among consumers regarding these products, addiction to the drug and hesitation among people to visit psychiatrists or neurologists in emerging countries would impede the growth of this market.

With the increasing number of nootropic consumers, more recently, the drug modafinil (brand name: Provigil) has become the brain-booster of choice. Modafinil is intended to improve wakefulness in people with narcolepsy, obstructive sleep apnea, or work condition change according to the FDA. But when people take it without these factors, it has been related to changes in alertness, strength, decision-making and concentration. Other leading pharmaceutical companies in this domain are focused on bringing new products in the market with multiple functions. For instance, Neurohacker Collective, the human optimization company, launched the first liquid nootropic, Qualia Nootropic Energy Shot, claimed to improve brain energy levels.

North America holds the highest market share in this industry with the highest number of nootropics consumers in the region. A large percentage of adult population in this region consumes multi-vitamin tablets for improving functional abilities. Moreover, the U.S. Food and Drug Administration has classified the nonprescription product as Generally Regarded as Safe (GRAS).

Further key findings from the report suggest

• The application type segment is dominated by the memory enhancement type nootropics owing to the challenging work environment demanding potential employees. It is anticipated to grow at a CAGR of 13.7 % during the forecast period.
• HVMN, a U.S. based manufacturer and seller of ketone associated products launched HVMN Ketone at the beginning of 2018, which is claimed to enhance both physical and cognitive performance.
• In recent years, consumer have shifted to organic nootropics as well such as coffee, matcha tea, green tea, kucha tea, spinach, beets, peanuts, eggs, liver, brahmi, arctic root, turmeric, ginseng, pine bark, and fish oil.
• According to the American Exercise Council (ACE), around 50% of the consumers in the U.S. prefer to buy natural ingredient products. The growth in vegan population is expected to drive demand for natural products in developed regions such as Europe and North America.
• Manufacturers for Nootropics are focused on natural ingredients to satisfy the growing demand. For instance, Gaia Herbs launched a new product in April 2019 called Bacopa a vegan supplement made using natural ingredient. It contains lemon balm, saffron and spearmint.
• North America remains the key revenue generating geographical segment in this market. The geographical segment accounted for USD 740.1 million in 2018. Availability presence of key market players in the region, rising focus on precision medicine, and rising awareness about nootropics applications, are among the key factors driving the market growth for Nootropics in this region
• The global Nootropics market is highly fragmented with major players like Accelerated Intelligence Inc., AlternaScript; HVMN, Onnit Labs, Inc., Peak Nootropics, Teva Pharmaceutical Industries, Purelife bioscience Co., Ltd., United Pharmacies, SupNootropic bio co., Ltd., and Powder City collectively constituting a competitive market.

To identify the key trends in the industry, click on the link below:   https://www.reportsanddata.com/report-detail/nootropics-market

For the purpose of this report, Reports and Data has segmented the Nootropics market on the basis of drugs type, application, distribution channel and region:

Drug Type Outlook (Revenue in Million USD; 2016–2026)

• Prescription Nootropics
  • Modafinil (Provigil)
  • Adderall
  • Methylphenidate (Ritalin)
  • Memantine (Axura)
• OTC Nootropics
  • Ginkgo Biloba
  • Panax Ginseng
  • Rhodiola Rosea
  • Nicotine
  • Caffeine
  • Racetams
    • Piracetam
    • Pramiracetam
    • Phenylpiracetam
    • Aniracetam
  • L-theanine
  • CDP-choline
  • Creatine monohydrate
  • Bacopa monnieri
  • Noopept
  • Omega-3 fatty acids

Application Outlook (Revenue in Million USD; 2016–2026)

• Memory Enhancement
• Mood & Depression
• Attention & Focus
• Longevity & Anti-aging
• Sleep & Recovery
• Anxiety

Distribution Channel Outlook (Revenue in Million USD; 2016–2026)

• Offline
• Online

Order Now: https://www.reportsanddata.com/checkout-form/2509

Regional Outlook (Revenue in Million USD; 2016–2026)

• North America
  • U.S
  • Canada
• Europe
  • Germany
  • France
  • U.K
  • Spain
  • Italy
  • Rest of the Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia-Pacific
• Middle East & Africa
• Latin America

Browse more similar reports on Diagnostics category by Reports And Data

Photomedicine Market - https://www.reportsanddata.com/report-detail/photomedicine-market

In-Vitro Diagnostics (IVD) Quality Control Market - https://www.reportsanddata.com/report-detail/in-vitro-diagnostics-ivd-quality-control-market

Point of Care (PoC) Diagnostics Market - https://www.reportsanddata.com/report-detail/point-of-care-poc-diagnostics-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John Watson

Head of Business Development

Reports And Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com